These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24579075)

  • 21. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis.
    Mimura T; Rizzello F; Helwig U; Poggioli G; Schreiber S; Talbot IC; Nicholls RJ; Gionchetti P; Campieri M; Kamm MA
    Gut; 2004 Jan; 53(1):108-14. PubMed ID: 14684584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B
    J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probiotic therapy to prevent pouchitis onset.
    Gionchetti P; Rizzello F; Poggioli G; Morselli C; Lammers KM; Campieri M
    Dis Colon Rectum; 2005 Jul; 48(7):1493; author reply 1493-4. PubMed ID: 15793632
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum alpha-1 antitrypsin: a noninvasive marker of pouchitis.
    Matalon S; Elad H; Brazowski E; Santo E; Tulchinsky H; Dotan I
    Inflamm Bowel Dis; 2015 Mar; 21(3):589-95. PubMed ID: 25659085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative?
    Campieri M; Gionchetti P
    Gastroenterology; 1999 May; 116(5):1246-9. PubMed ID: 10220518
    [No Abstract]   [Full Text] [Related]  

  • 26. Fecal calprotectin mirrors inflammation of the distal ileum and bowel function after restorative proctocolectomy for pediatric-onset ulcerative colitis.
    Pakarinen MP; Koivusalo A; Natunen J; Ashorn M; Karikoski R; Aitola P; Rintala RJ; Kolho KL
    Inflamm Bowel Dis; 2010 Mar; 16(3):482-6. PubMed ID: 19685453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis.
    Persborn M; Gerritsen J; Wallon C; Carlsson A; Akkermans LM; Söderholm JD
    Aliment Pharmacol Ther; 2013 Oct; 38(7):772-83. PubMed ID: 23957603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea.
    Chatterjee S; Kar P; Das T; Ray S; Gangulyt S; Rajendiran C; Mitra M
    J Assoc Physicians India; 2013 Oct; 61(10):708-12. PubMed ID: 24772726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions among lactic acid starter and probiotic bacteria used for fermented dairy products.
    Vinderola CG; Mocchiutti P; Reinheimer JA
    J Dairy Sci; 2002 Apr; 85(4):721-9. PubMed ID: 12018416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The current place of probiotics and prebiotics in the treatment of pouchitis.
    Lichtenstein L; Avni-Biron I; Ben-Bassat O
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):73-80. PubMed ID: 27048898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial.
    Jain PK; McNaught CE; Anderson AD; MacFie J; Mitchell CJ
    Clin Nutr; 2004 Aug; 23(4):467-75. PubMed ID: 15297081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients.
    Chitapanarux I; Chitapanarux T; Traisathit P; Kudumpee S; Tharavichitkul E; Lorvidhaya V
    Radiat Oncol; 2010 May; 5():31. PubMed ID: 20444243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases.
    Chapman TM; Plosker GL; Figgitt DP
    Drugs; 2006; 66(10):1371-87. PubMed ID: 16903771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice.
    Shen B; Brzezinski A; Fazio VW; Remzi FH; Achkar JP; Bennett AE; Sherman K; Lashner BA
    Aliment Pharmacol Ther; 2005 Oct; 22(8):721-8. PubMed ID: 16197493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
    Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kanarek E; Sowińska A; Cukrowska B
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.
    Johnson MW; Maestranzi S; Duffy AM; Dewar DH; Forbes A; Bjarnason I; Sherwood RA; Ciclitira P; Nicholls JR
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):174-9. PubMed ID: 18301296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of probiotics in the management of pouchitis.
    Guslandi M
    Curr Pharm Des; 2014; 20(28):4561-4. PubMed ID: 24180410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children.
    Grandy G; Medina M; Soria R; Terán CG; Araya M
    BMC Infect Dis; 2010 Aug; 10():253. PubMed ID: 20735858
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Xu YY; Zhang YY; He AQ; Li KY; Gao SY; Liu G
    World J Gastroenterol; 2017 Jul; 23(26):4735-4743. PubMed ID: 28765694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoluminal calprotectin measurement in assessment of pouchitis and a new index of disease activity: a pilot study.
    Pronio A; Di Filippo AR; Mariani P; Vestri A; Montesani C; Boirivant M
    Rev Esp Enferm Dig; 2016 Apr; 108(4):190-5. PubMed ID: 26901424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.